Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib

BACKGROUND: Dermatologic adverse events (DAEs) are associated with a better outcome in patients with hepatocellular carcinoma (HCC) irrespective of the therapeutic agent received. The exact mechanisms associated with the development of DAEs are unknown although several studies point to direct toxici...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapena, Víctor, Iavarone, Massimo, Boix, Loreto, Facchetti, Floriana, Guarino, Maria, Sanduzzi Zamparelli, Marco, Granito, Alessandro, Samper, Esther, Scartozzi, Mario, Corominas, Josep, Marisi, Giorgia, Díaz, Alba, Casadei-Gardini, Andrea, Gramantieri, Laura, Lampertico, Pietro, Morisco, Filomena, Torres, Ferran, Bruix, Jordi, Reig, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376774/
https://www.ncbi.nlm.nih.gov/pubmed/36158918
http://dx.doi.org/10.4254/wjh.v14.i7.1438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376774/
https://www.ncbi.nlm.nih.gov/pubmed/36158918
http://dx.doi.org/10.4254/wjh.v14.i7.1438

Ejemplares similares